New Weight-Loss shot shows promise in early trial
NCT ID NCT06471530
First seen Jan 11, 2026 · Last updated May 08, 2026 · Updated 19 times
Summary
This early-stage study tested a new drug called TE-8105 in 38 overweight or obese adults who do not have diabetes. The main goal was to check if the drug is safe and to see how it affects body weight. Participants received one or more doses of the drug, and researchers monitored side effects and weight changes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT AND OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CMAX Clinical Research
Adelaide, South Australia, 5000, Australia
Conditions
Explore the condition pages connected to this study.